Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbasone Mobile LLC was a specialized healthcare service provider and subsidiary of Orthometrix, Inc., established in 2006 to offer mobile Extracorporeal Shock Wave Therapy (ESWT). The company focused on providing the Orbasone Pain Relief System, an FDA-cleared medical device, to podiatric and orthopedic practices for the treatment of chronic plantar fasciitis. By utilizing a mobile service model, Orbasone Mobile enabled physicians to offer advanced ESWT treatments in their own offices or ambulatory surgical centers without the need for capital equipment purchases. The company also provided comprehensive insurance billing support through partnerships, facilitating the adoption of ESWT technology in the clinical setting. At its peak, the company operated across multiple regions in the United States, serving as a key marketing and service arm for the Orbasone technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbasone Mobile.